RhumbLine Advisers’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-317,104
| Closed | -$14.7M | – | 2984 |
|
|
2019
Q2 | $14.7M | Buy |
317,104
+28,153
| +10% | +$1.3M | 0.03% | 585 |
|
|
2019
Q1 | $7.05M | Buy |
288,951
+9,293
| +3% | +$227K | 0.01% | 969 |
|
|
2018
Q4 | $3.99M | Buy |
279,658
+92,402
| +49% | +$1.32M | 0.01% | 1238 |
|
|
2018
Q3 | $2.85M | Sell |
187,256
-13,700
| -7% | -$208K | 0.01% | 1460 |
|
|
2018
Q2 | $3.37M | Buy |
200,956
+7,178
| +4% | +$120K | 0.01% | 1366 |
|
|
2018
Q1 | $3.16M | Buy |
193,778
+967
| +0.5% | +$15.8K | 0.01% | 1333 |
|
|
2017
Q4 | $2.47M | Sell |
192,811
-17,874
| -8% | -$229K | 0.01% | 1503 |
|
|
2017
Q3 | $2.59M | Buy |
210,685
+5,420
| +3% | +$66.7K | 0.01% | 1442 |
|
|
2017
Q2 | $1.72M | Sell |
205,265
-7,817
| -4% | -$65.4K | ﹤0.01% | 1675 |
|
|
2017
Q1 | $1.91M | Buy |
213,082
+11,500
| +6% | +$103K | ﹤0.01% | 1579 |
|
|
2016
Q4 | $1.77M | Buy |
201,582
+21,372
| +12% | +$188K | ﹤0.01% | 1520 |
|
|
2016
Q3 | $1.22M | Sell |
180,210
-400
| -0.2% | -$2.7K | ﹤0.01% | 1711 |
|
|
2016
Q2 | $643K | Buy |
180,610
+18,403
| +11% | +$65.5K | ﹤0.01% | 2034 |
|
|
2016
Q1 | $479K | Buy |
162,207
+4,780
| +3% | +$14.1K | ﹤0.01% | 2256 |
|
|
2015
Q4 | $664K | Buy |
157,427
+15,235
| +11% | +$64.3K | ﹤0.01% | 2071 |
|
|
2015
Q3 | $648K | Buy |
142,192
+5,684
| +4% | +$25.9K | ﹤0.01% | 2058 |
|
|
2015
Q2 | $984K | Sell |
136,508
-4,415
| -3% | -$31.8K | ﹤0.01% | 1883 |
|
|
2015
Q1 | $1.04M | Buy |
140,923
+18,825
| +15% | +$139K | ﹤0.01% | 1838 |
|
|
2014
Q4 | $578K | Buy |
122,098
+5,325
| +5% | +$25.2K | ﹤0.01% | 2194 |
|
|
2014
Q3 | $417K | Hold |
116,773
| – | – | ﹤0.01% | 2327 |
|
|
2014
Q2 | $532K | Buy |
116,773
+12,333
| +12% | +$56.2K | ﹤0.01% | 2238 |
|
|
2014
Q1 | $491K | Sell |
104,440
-5,020
| -5% | -$23.6K | ﹤0.01% | 2243 |
|
|
2013
Q4 | $548K | Hold |
109,460
| – | – | ﹤0.01% | 2196 |
|
|
2013
Q3 | $681K | Sell |
109,460
-1,035
| -0.9% | -$6.44K | ﹤0.01% | 2022 |
|
|
2013
Q2 | $502K | Buy |
+110,495
| New | +$502K | ﹤0.01% | 2252 |
|